EUGLENA CO., LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 540 JPY | -1.10% |
|
+1.50% | -22.53% |
| Sales 2022 | 44.39B 282M | Sales 2023 | 46.48B 295M | Capitalization | 81.64B 519M |
|---|---|---|---|---|---|
| Net income 2022 | -2.67B -16.98M | Net income 2023 | -2.65B -16.85M | EV / Sales 2022 | 2.77 x |
| Net Debt 2022 | 12.27B 77.93M | Net Debt 2023 | 9.28B 58.96M | EV / Sales 2023 | 1.96 x |
| P/E ratio 2022 |
-41.1
x | P/E ratio 2023 |
-30.6
x | Employees | 846 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 71.16% |
More Fundamentals
* Assessed data
More news
More press releases
More news
| 1 day | -1.10% | ||
| 1 week | +1.50% | ||
| 1 month | +3.85% | ||
| 3 months | -12.34% | ||
| 6 months | -27.61% | ||
| Current year | -22.53% |
1 week
533.00
570.00
1 month
503.00577.00
Current year
500.00720.00
1 year
500.00928.00
3 years
500.001 108.00
5 years
498.001 295.00
10 years
498.002 177.00
| Managers | Title | Age | Since |
|---|---|---|---|
Akihiko Nagata
CEO | Chief Executive Officer | 41 | 08-11-30 |
| Founder | 48 | 05-08-08 | |
Kengo Suzuki
FOU | Founder | 44 | 05-08-08 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Win Sen Tan
BRD | Director/Board Member | 41 | - |
Mitsuru Izumo
FOU | Founder | 44 | 05-08-08 |
Kengo Suzuki
FOU | Founder | 44 | 05-08-08 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.51% | 12 M€ | +8.43% | ||
| 0.02% | 17 M€ | +14.54% | - | |
| 0.02% | 746 M€ | -.--% | - | |
| 0.02% | 20,360 M€ | +16.70% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-31 | 540 | -1.10% | 559,500 |
| 24-05-30 | 546 | +0.18% | 384,700 |
| 24-05-29 | 545 | -1.09% | 472,800 |
| 24-05-28 | 551 | -1.96% | 860,600 |
| 24-05-27 | 562 | +5.64% | 859,300 |
Delayed Quote Japan Exchange, May 31, 2024 at 02:00 am EDT
More quotes
euglena Co., Ltd. is a Japan-based company mainly engaged in the healthcare, energy and environmental business utilizing the research and development results on euglena. The Company masters the core technology of euglena, which provides the edibility of microalga euglena (Japanese name: Midorimushi) and the technology of outdoor large-scale cultivation. The Company operates in two business segments. The Healthcare segment is involved in the original equipment manufacturer (OEM) provision of food and cosmetics using euglena, as well as the planning and sale of products. The Energy and Environment segment is involved in the technology development and commissioned research of euglena and other microalgae, as well as the research and development of biofuels for the future commercialization.
Sector
Food Processing
Calendar
2024-08-07
- Q3 2024 Earnings Release (Projected)
Sell
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
540
JPY
Average target price
1,000
JPY
Spread / Average Target
+85.19%
| 1st Jan change | Capi. | |
|---|---|---|
| -22.53% | 468M | |
| +11.85% | 8.05B | |
| +5.29% | 7.59B | |
| +2.63% | 6.07B | |
| -2.80% | 3.85B | |
| -11.22% | 3.55B | |
| -7.04% | 1.28B | |
| -32.50% | 1.03B | |
| +12.52% | 971M | |
| -11.19% | 907M |
- Stock Market
- Equities
- 2931 Stock
